Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M187Revenue $M0.5Net Margin (%)0Z-Score25.0
Enterprise Value $M145EPS $-0.3Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %-3.5Quick Ratio7.7Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-15.9Current Ratio7.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-39.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-48.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M67.2ROI % (ttm)-93.3Gross Margin Increase y-yN

Gurus Latest Trades with CPRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CPRX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CPRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MUTH DAVID DExec. V.P., Corp. Development 2014-10-03Buy10,000$2.652.26 view
MUTH DAVID DExec. V.P., Corp. Development 2014-08-28Sell0$02.26 view
Miller SteveCOO 2014-06-04Buy100,000$2.1724.88 view
MCENANY PATRICK JPresident and CEO 2014-05-21Buy25,000$1.8943.39 view
O'Keeffe Charles BDirector 2014-05-19Buy10,000$1.8348.09 view
O'Keeffe Charles BDirector 2014-04-16Buy5,000$2.0234.16 view
MCENANY PATRICK JPresident and CEO 2014-02-07Buy25,000$1.8248.9 view
O'Keeffe Charles BDirector 2014-02-05Buy10,000$1.8149.72 view
Tierney David SDirector 2013-10-23Buy8,000$2.0333.5 view
O'Keeffe Charles BDirector 2013-10-21Buy10,000$1.8447.28 view

Press Releases about CPRX :

    Quarterly/Annual Reports about CPRX:

    News about CPRX:

    Articles On GuruFocus.com
    Largest Insider Buys of the Week Oct 25 2013 
    Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
    Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN Jun 04 2012 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 15 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Aug 12 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 9,359 Shares Jun 16 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) May 17 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 25,000 Shares Nov 16 2009 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 12 2009 
    Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results Aug 07 2009 

    More From Other Websites
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Nov 24 2014
    Catalyst Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application for the Reduction... Nov 24 2014
    8:04 am Catalyst Pharma announces notice of allowance of U.S. Patent Application for the reduction... Nov 24 2014
    Catalyst Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application for the Reduction... Nov 24 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Financials Nov 21 2014
    10-Q for Catalyst Pharmaceutical Partners, Inc. Nov 15 2014
    Catalyst Pharmaceuticals Announces Third Quarter 2014 Financial Results Nov 14 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Nov 14 2014
    Catalyst Pharmaceuticals Announces Third Quarter 2014 Financial Results Nov 14 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report Nov 13 2014
    Will Catalyst Pharmaceuticals' (CPRX) Loss Narrow in Q3? Nov 12 2014
    Catalyst Pharmaceuticals Announces Proposed Settlement of Pending Securities Class Action Lawsuit Nov 04 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Nov 04 2014
    Catalyst Pharmaceuticals Announces Proposed Settlement of Pending Securities Class Action Lawsuit Nov 04 2014
    Catalyst Pharmaceuticals Appoints David J. Caponera as Vice President Patient Advocacy and... Oct 28 2014
    Catalyst Pharmaceuticals Appoints David J. Caponera as Vice President Patient Advocacy and... Oct 28 2014
    Catalyst Pharmaceuticals to Present Firdapse Phase 3 Trial Results at the 61st Annual Meeting of the... Oct 27 2014
    Catalyst Pharmaceuticals to Present Firdapse Phase 3 Trial Results at the 61st Annual Meeting of the... Oct 27 2014
    Midday Gainers From October 8 - GT Advanced Technologies Inc, Unilife Corp And More Oct 08 2014
    Catalyst Pharmaceuticals to Present Top-Line Safety and Efficacy Results From Phase 3 Firdapse Trial... Oct 08 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK